We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

237 hedge funds and large institutions have $3.87B invested in Arena Pharmaceuticals Inc in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 82 increasing their positions, 71 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

107% more call options, than puts

Call options by funds: $30.5M | Put options by funds: $14.7M

15% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 71

9% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 35

1% more funds holding

Funds holding: 235237 (+2)

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

1% less capital invested

Capital invested by funds: $3.89B → $3.87B (-$22.7M)

Holders
237
Holders Change
+2
Holders Change %
+0.85%
% of All Funds
4.13%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
38
Increased
82
Reduced
71
Closed
35
Calls
$30.5M
Puts
$14.7M
Net Calls
+$15.7M
Net Calls Change
+$4.31M
Name Holding Trade Value Shares
Change
Change in
Stake
TRSOTSOK
76
Teachers Retirement System of the State of Kentucky
Kentucky
$5.24M +$143K +2,198 +3%
Janus Henderson Group
77
Janus Henderson Group
United Kingdom
$5.22M +$1.25M +19,166 +33%
Bank of America
78
Bank of America
North Carolina
$5.21M -$807K -12,378 -14%
Citigroup
79
Citigroup
New York
$5.06M +$610K +9,362 +14%
SEI Investments
80
SEI Investments
Pennsylvania
$4.98M +$547K +8,393 +13%
Thrivent Financial for Lutherans
81
Thrivent Financial for Lutherans
Minnesota
$4.89M +$76.3K +1,170 +2%
New York State Common Retirement Fund
82
New York State Common Retirement Fund
New York
$4.54M +$83.6K +1,282 +2%
Schroder Investment Management Group
83
Schroder Investment Management Group
United Kingdom
$4.51M +$416K +6,384 +11%
Allianz Asset Management
84
Allianz Asset Management
Germany
$4.49M +$337K +5,170 +9%
PPA
85
Parametric Portfolio Associates
Washington
$4.1M -$865K -13,276 -18%
RPAM
86
Rhenman & Partners Asset Management
Sweden
$4.09M
Invesco
87
Invesco
Georgia
$3.68M +$448K +6,869 +15%
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
$3.33M -$2.34M -35,864 -42%
HI
89
Handelsinvest Investeringsforvaltning
Denmark
$3.21M
Hudson Bay Capital Management
90
Hudson Bay Capital Management
Connecticut
$3.07M +$2.93M +45,000 New
GC
91
Guggenheim Capital
Illinois
$2.94M +$142K +2,176 +5%
SCF
92
Sante Capital Fund
Texas
$2.83M +$2.71M +41,502 New
State of New Jersey Common Pension Fund D
93
State of New Jersey Common Pension Fund D
New Jersey
$2.78M +$141K +2,157 +6%
Rafferty Asset Management
94
Rafferty Asset Management
New York
$2.73M -$209K -3,210 -7%
BC
95
Brookfield Corp
Ontario, Canada
$2.72M +$1.27M +19,505 +96%
Victory Capital Management
96
Victory Capital Management
Texas
$2.71M -$368K -5,638 -12%
Legal & General Group
97
Legal & General Group
United Kingdom
$2.62M -$50.7K -778 -2%
MOACM
98
Mutual of America Capital Management
New York
$2.44M +$2.33M +35,817 New
Manulife (Manufacturers Life Insurance)
99
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.34M +$111K +1,701 +5%
T. Rowe Price Associates
100
T. Rowe Price Associates
Maryland
$2.04M -$145K -2,227 -7%

ARNA Hedge Fund Activity: Q2 2021 in Review

237 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2021, worth a combined $3.87B — down 0.58% from $3.89B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ARNA positions and 35 closed out — a net gain of 3 holders — while 82 added to existing stakes and 71 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $57.4M. The largest seller was AllianceBernstein, cutting an estimated $57M.

  • 237 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2021, up from 235 in Q1 2021.
  • Funds reported $3.87B of Arena Pharmaceuticals Inc stock for Q2 2021, down 0.58% quarter-over-quarter.
  • 38 funds opened new Arena Pharmaceuticals Inc positions in Q2 2021 and 35 closed out, a net change of +3 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2021 was JP Morgan Chase, an estimated $57.4M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2021 was AllianceBernstein, an estimated $57M sold.

Based on aggregated 13F filings for Q2 2021.